Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Poynard

Showing results (1-10 of 272) with videos related to

Pageof 28
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
Treatment of cirrhotic patients in the pegylated interferon eraThierry Poynard
Seminars in Liver Disease|September 4, 2004
Treatment of hepatitis C virus: the first decadeThierry Poynard
Journal of Hepatology|November 20, 2010
First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsyThierry Poynard
Gastroenterologie Clinique Et Biologique|October 31, 2003
[Should we have the courage to say no to systematic liver biopsy?]Thierry Poynard
Gastroenterologie Clinique Et Biologique|November 4, 2004
[The Fibrotest is an ethical choice because it is a cost-effective and anti-inflationistic test. Response to Jean Louis Payen and Jean Marie Combis]Thierry Poynard
Lancet (London, England)|May 4, 2002
Uses of errorThierry Poynard
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Long-term outcome improvement in patients with chronic hepatitis D treated with interferon alphaVlad Ratziu, Thierry Poynard
Journal of Hepatology|January 8, 2004
Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virusYves Benhamou, Thierry Poynard
The New England Journal of Medicine|March 14, 2009
Prolonged therapy for hepatitis C with low-dose peginterferonThierry Poynard, Vlad Ratziu
Hepatology (Baltimore, Md.)|September 29, 2006
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get seriousVlad Ratziu, Thierry Poynard
Pageof 28

Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
Treatment of cirrhotic patients in the pegylated interferon eraThierry Poynard
Seminars in Liver Disease|September 4, 2004
Treatment of hepatitis C virus: the first decadeThierry Poynard
Journal of Hepatology|November 20, 2010
First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsyThierry Poynard
Gastroenterologie Clinique Et Biologique|October 31, 2003
[Should we have the courage to say no to systematic liver biopsy?]Thierry Poynard
Gastroenterologie Clinique Et Biologique|November 4, 2004
[The Fibrotest is an ethical choice because it is a cost-effective and anti-inflationistic test. Response to Jean Louis Payen and Jean Marie Combis]Thierry Poynard
Lancet (London, England)|May 4, 2002
Uses of errorThierry Poynard
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Long-term outcome improvement in patients with chronic hepatitis D treated with interferon alphaVlad Ratziu, Thierry Poynard
Journal of Hepatology|January 8, 2004
Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virusYves Benhamou, Thierry Poynard
The New England Journal of Medicine|March 14, 2009
Prolonged therapy for hepatitis C with low-dose peginterferonThierry Poynard, Vlad Ratziu
Hepatology (Baltimore, Md.)|September 29, 2006
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get seriousVlad Ratziu, Thierry Poynard
Pageof 28